Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XENUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCVORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCVNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.31.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.31.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.31.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.31.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.78ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.78NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HR.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HR.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HS.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HS.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HS.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HH.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HH.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HU.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HU.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HU.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HU.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used